{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:51:42Z","timestamp":1773888702124,"version":"3.50.1"},"reference-count":17,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2026,3,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Following the global mpox outbreak in 2022, cases have continued to occur in England at a low but persistent rate. Differences in access or application of testing along with widespread roll-out of vaccination (which may affect the clinical presentation of infection) may lead to under-detection of cases. We sought to investigate the prevalence of potentially undiagnosed clade IIb mpox using residual samples from men tested for suspected lymphogranuloma venereum (LGV) or syphilis infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Anonymised, residual DNA extracts from specimens (including urogenital swabs, rectal swabs and ulcer swabs) from men referred to the national UK Health Security Agency Sexually Transmitted Infections Reference Laboratory between 1 October and 30 November 2024 (inclusive), for LGV or syphilis detection, were tested using a dual-clade monkeypox virus (MPXV) real-time PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1043 (805\/1043, 77.2% requested for LGV; 238\/1043, 22.8% requested for syphilis) anonymised DNA extracts were tested for MPXV. Four (4\/1043, 0.38%; 95% CI 0.1 to 0.9) extracts tested positive for mpox, 3\/805 (0.37%; 95% CI 0.08 to 1.09) were from LGV referrals and 1\/238 (0.42%; 95% CI 0.01 to 2.32) was from a syphilis referral. Clade typing was successful for \u00be mpox-positive samples, all were clade II.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identified a small number of mpox cases in England that may not have been detected using the standard diagnostic and clinical pathways. This study represents proof of concept for rapid assessment of the scale of missed cases and could be repeated should shifts in epidemiology suggest an increase in undiagnosed cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/sextrans-2025-056867","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:35:26Z","timestamp":1773873326000},"page":"sextrans-2025-056867","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the possibility of undetected MPOX cases in England: results from the advanced mpox laboratory investigation for finding the undetected (AMPLIFY) study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-5935","authenticated-orcid":false,"given":"Rachel","family":"Pitt-Kendall","sequence":"first","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6707-6910","authenticated-orcid":false,"given":"Michelle Jayne","family":"Cole","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shridaniya","family":"Sunthararajah","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Millward","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Charles","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2060-7286","authenticated-orcid":false,"given":"Hamish","family":"Mohammed","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Viviani","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Phillips","sequence":"additional","affiliation":[{"name":"Croydon University Hospital, Croydon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Phillips","sequence":"additional","affiliation":[{"name":"North Cumbria Integrated Care NHS Foundation Trust, Penrith, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Fifer","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy","family":"Sinka","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9086-9222","authenticated-orcid":false,"given":"Sarah","family":"Alexander","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2026031815351929000_sextrans-2025-056867v1.1","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuaf025","article-title":"Mpox: current knowledge and understanding-a scoping review","volume":"49","author":"Callaby","year":"2025","journal-title":"FEMS Microbiol Rev"},{"key":"2026031815351929000_sextrans-2025-056867v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(22)00228-6"},{"key":"2026031815351929000_sextrans-2025-056867v1.3","unstructured":"UK Health Security Agency . Mpox vaccination: information for healthcare practitioners. 2025. Available: https:\/\/www.gov.uk\/government\/publications\/vaccination-against-mpox-information-for-healthcare-practitioners\/mpox-vaccination-information-for-healthcare-practitioners"},{"key":"2026031815351929000_sextrans-2025-056867v1.4","unstructured":"UK Health Security Agency . Mpox outbreak: epidemiologoical overveiw. 2025. Available: https:\/\/www.gov.uk\/government\/publications\/monkeypox-outbreak-epidemiological-overview\/mpox-outbreak-epidemiological-overview-11-september-2025"},{"key":"2026031815351929000_sextrans-2025-056867v1.5","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3201\/eid3010.240292","article-title":"Mpox Epidemiology and Vaccine Effectiveness, England, 2023","volume":"30","author":"Charles","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"2026031815351929000_sextrans-2025-056867v1.6","unstructured":"UK Health Security Agency . Mpox: diagnostic testing. 2025. Available: https:\/\/www.gov.uk\/guidance\/monkeypox-diagnostic-testing"},{"key":"2026031815351929000_sextrans-2025-056867v1.7","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00220-8","article-title":"Breakthrough atypical mpox in a vaccinated individual with high antibody titres","volume":"25","author":"Byrne","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026031815351929000_sextrans-2025-056867v1.8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/DAD.0000000000002945","article-title":"Atypical Mpox Cutaneous Presentation After Full Vaccination","volume":"47","author":"Schreidah","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"2026031815351929000_sextrans-2025-056867v1.9","doi-asserted-by":"publisher","DOI":"10.1177\/0956462413482811"},{"key":"2026031815351929000_sextrans-2025-056867v1.10","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/09564624241280406","article-title":"BASHH UK guidelines for the management of syphilis 2024","volume":"35","author":"Kingston","year":"2024","journal-title":"Int J STD AIDS"},{"key":"2026031815351929000_sextrans-2025-056867v1.11","unstructured":"UK Health Security Agency . Sexually transmitted infections (STIs): annual data. 2025. Available: https:\/\/www.gov.uk\/government\/statistics\/sexually-transmitted-infections-stis-annual-data-tables"},{"key":"2026031815351929000_sextrans-2025-056867v1.12","unstructured":"UK Health Security Agency . Mpox outbreak: epidemiological overview. 2024. Available: https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20250128213000\/https:\/\/www.gov.uk\/government\/publications\/monkeypox-outbreak-epidemiological-overview\/mpox-outbreak-epidemiological-overview-7-november-2024"},{"key":"2026031815351929000_sextrans-2025-056867v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2010.07.012"},{"key":"2026031815351929000_sextrans-2025-056867v1.14","unstructured":"UK Health Security Agency . Mpox: guidance on when to suspect a case of mpox. 2025. Available: https:\/\/www.gov.uk\/guidance\/monkeypox-case-definitions"},{"key":"2026031815351929000_sextrans-2025-056867v1.15","unstructured":"Coleman HS , Soni I , Murchie S , et al . BASHH summary guidance on testing for sexually transmitted infections. 2023. Available: https:\/\/www.bashh.org\/_userfiles\/pages\/files\/resources\/bashh_summary_guidance_on_stis_testing_2023.pdf"},{"key":"2026031815351929000_sextrans-2025-056867v1.16","unstructured":"UK Health Security Agency . Mpox control: UK strategy 2025 to 2026. 2025. Available: https:\/\/www.gov.uk\/government\/publications\/mpox-control-and-elimination-uk-strategy-2025-to-2026\/mpox-control-uk-strategy-2025-to-2026#levels-of-mpox-transmission"},{"key":"2026031815351929000_sextrans-2025-056867v1.17","first-page":"1","article-title":"BASHH Annual Conference 2025, Edinburgh, UK, June 9\u201311 2025","volume":"36","year":"2025","journal-title":"Int J STD AIDS"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2025-056867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:35:28Z","timestamp":1773873328000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2025-056867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":17,"alternative-id":["10.1136\/sextrans-2025-056867"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2025-056867","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}